A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)
The purpose of this study is to evaluate the efficacy of pregabalin compared to placebo in reducing neuropathic pain associated with HIV neuropathy.
Based on DMC interim efficacy analysis results indicating a low probability for success the study was terminated on April 2, 2012; the termination was unrelated to any safety findings that could impact patient health.
Inclusion Criteria:
Exclusion Criteria:
Palm Springs, California 92262, United States
Bogota, Cundinamarca 0000, Colombia
Bogota, Cundinamarca, Colombia
Bogotá, Cundinamarca 0000, Colombia
Bucaramanga, Santander Department 0000, Colombia
Hyderabad, Andhra Pradesh 500 004, India
Hyderabad, Andhra Pradesh 500 072, India
Johannesburg, Gauteng 2193, South Africa
Gauteng, 2047, South Africa
Tygerberg, 7505, South Africa